EORTC Mobile Devices (EMBED): Defining an Implementation Strategy for the Digital Assessment of Quality of Life and Objective Patient Measures in EORTC Clinical Trials

In line with the aim of the EORTC Quality of Life Group (QLG) to “investigate the use of new personal technologies to assess patient’s PRO/ HRQoL in clinical trials, research studies, and routine clinical practice”, this study will position the European Organisation for Research and Treatment of Cancer (EORTC) and QLG in the rapidly evolving field of smart devices in oncology, with potential benefits in relation with the current trends in the pharmaceutical field.

Principal Investigator

Quality of Life Department, EORTC Headquarters, Brussels, Belgium
Dr. Andrew Bottomley

The project is funded by the EORTC.

Principal Investigators in Geneva

University of Geneva, Switzerland
Prof. Katarzyna Wac, GSEM, CUI, QoL Technologies Lab Director

University of Geneva Hospitals & University of Geneva, Switzerland (forthcoming)
Dre Thanh Lam, MD, Breast Cancer Centre, Geneva University Hospitals, Switzerland